Exact Mass: 677.2167034

Exact Mass Matches: 677.2167034

Found 23 metabolites which its exact mass value is equals to given mass value 677.2167034, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

   

O2,O6-Dideacetylevonine

O2,O6-Dideacetylevonine

C32H39NO15 (677.2319584)


   
   

Octa-Ac-6-O-(2-Amino-2-deoxy-beta-D-glucopyranoxyl)-D-galactose

Octa-Ac-6-O-(2-Amino-2-deoxy-beta-D-glucopyranoxyl)-D-galactose

C28H39NO18 (677.2167034)


   

1,6-bis-deacetyl evonine

1,6-bis-deacetyl evonine

C32H39NO15 (677.2319584)


   

N-Acetyl-D-lactosamine heptaacetate

N-Acetyl-D-lactosamine heptaacetate

C28H39NO18 (677.2167034)


   

CKD-711|O-[4-deoxy-4-(2,3-epoxy-3-hydroxymethyl-4,5,6-trihydroxycyclohexane-1-yl-amino)-alpha-D-glucopyranosyl]-(1->4)-O-alpha-D-glucopyranosyl-(1->4)-alpha-D-glucopyranose

CKD-711|O-[4-deoxy-4-(2,3-epoxy-3-hydroxymethyl-4,5,6-trihydroxycyclohexane-1-yl-amino)-alpha-D-glucopyranosyl]-(1->4)-O-alpha-D-glucopyranosyl-(1->4)-alpha-D-glucopyranose

C25H43NO20 (677.2378318000001)


   

C32H39NO15_(1S,3R,13S,14S,17S,18R,19R,20S,21S,23R,24R,25S)-20-(Acetoxymethyl)-18,24,25-trihydroxy-3,13,14,25-tetramethyl-6,15,22-trioxo-2,5,16-trioxa-11-azapentacyclo[15.7.1.0~1,20~.0~3,23~.0~7,12~]pentacosa-7,9,11-triene-19,21-diyl diacetate

NCGC00385597-01_C32H39NO15_(1S,3R,13S,14S,17S,18R,19R,20S,21S,23R,24R,25S)-20-(Acetoxymethyl)-18,24,25-trihydroxy-3,13,14,25-tetramethyl-6,15,22-trioxo-2,5,16-trioxa-11-azapentacyclo[15.7.1.0~1,20~.0~3,23~.0~7,12~]pentacosa-7,9,11-triene-19,21-diyl diacetate

C32H39NO15 (677.2319584)


   
   

1-(3-sulfopropyl)-2-[[3-(3-sulfopropyl)-2(3h)-benzothiazolylidene]methyl] naphtho[1,2-d]thiazolium hydroxide, inner salt, triethylammonium salt

1-(3-sulfopropyl)-2-[[3-(3-sulfopropyl)-2(3h)-benzothiazolylidene]methyl] naphtho[1,2-d]thiazolium hydroxide, inner salt, triethylammonium salt

C31H39N3O6S4 (677.1721593999999)


   

Gisadenafil besylate

Gisadenafil besylate

C29H39N7O8S2 (677.2301414000001)


C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor > C2127 - cGMP Phosphodiesterase Inhibitor

   

2-{4-[2-(S)-Allyloxycarbonylamino-3-{4-[(2-carboxy-phenyl)-oxalyl-amino]-phenyl}-propionylamino]-butoxy}-6-hydroxy-benzoic acid methyl ester

2-{4-[2-(S)-Allyloxycarbonylamino-3-{4-[(2-carboxy-phenyl)-oxalyl-amino]-phenyl}-propionylamino]-butoxy}-6-hydroxy-benzoic acid methyl ester

C34H35N3O12 (677.222063)


   

(2R)-2-{[2-acetamido-3-O-(2-acetamido-2-deoxy-alpha-D-glucopyranosyl)-6-O-{[(5-aminopentyl)oxy](hydroxy)phosphoryl}-2-deoxy-alpha-D-glucopyranosyl]oxy}-3-hydroxypropanoic acid

(2R)-2-{[2-acetamido-3-O-(2-acetamido-2-deoxy-alpha-D-glucopyranosyl)-6-O-{[(5-aminopentyl)oxy](hydroxy)phosphoryl}-2-deoxy-alpha-D-glucopyranosyl]oxy}-3-hydroxypropanoic acid

C24H44N3O17P (677.2408224000001)


   

Frakefamide (TFA)

Frakefamide (TFA)

C32H35F4N5O7 (677.2472488000001)


Frakefamide TFA is a potent analgesic that acts as a peripheral active μ-selective receptor agonist. Frakefamide is unable to penetrate the blood-brain-barrier and enter the central nervous system[1][2].

   

5-[(6-{[4,5-dihydroxy-2-(hydroxymethyl)-6-{[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxan-3-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl)amino]-1-(hydroxymethyl)-7-oxabicyclo[4.1.0]heptane-2,3,4-triol

5-[(6-{[4,5-dihydroxy-2-(hydroxymethyl)-6-{[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxan-3-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl)amino]-1-(hydroxymethyl)-7-oxabicyclo[4.1.0]heptane-2,3,4-triol

C25H43NO20 (677.2378318000001)


   

1,6-bis-deacetyl evonine

NA

C32H39NO15 (677.2319584)


{"Ingredient_id": "HBIN001843","Ingredient_name": "1,6-bis-deacetyl evonine","Alias": "NA","Ingredient_formula": "C32H39NO15","Ingredient_Smile": "CC1C(C(=O)OC2C(C(C3(C(C(=O)C4C(C3(C2(C)O)OC4(COC(=O)C5=C1N=CC=C5)C)O)OC(=O)C)COC(=O)C)O)OC(=O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2438","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

[(1s,3r,13s,14r,17s,18r,19r,20s,21s,23r,24r,25s)-18,21-bis(acetyloxy)-19,24,25-trihydroxy-3,13,14,25-tetramethyl-6,15,22-trioxo-2,5,16-trioxa-11-azapentacyclo[15.7.1.0¹,²⁰.0³,²³.0⁷,¹²]pentacosa-7,9,11-trien-20-yl]methyl acetate

[(1s,3r,13s,14r,17s,18r,19r,20s,21s,23r,24r,25s)-18,21-bis(acetyloxy)-19,24,25-trihydroxy-3,13,14,25-tetramethyl-6,15,22-trioxo-2,5,16-trioxa-11-azapentacyclo[15.7.1.0¹,²⁰.0³,²³.0⁷,¹²]pentacosa-7,9,11-trien-20-yl]methyl acetate

C32H39NO15 (677.2319584)


   

(2r,3s,4r,5r)-4-{[(2r,3r,4s,5r,6r)-5-{[(2r,3r,4s,5r,6s)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(1r,2r,3s,4r,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)-7-oxabicyclo[4.1.0]heptan-2-yl]amino}oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3,5,6-tetrahydroxyhexanal

(2r,3s,4r,5r)-4-{[(2r,3r,4s,5r,6r)-5-{[(2r,3r,4s,5r,6s)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(1r,2r,3s,4r,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)-7-oxabicyclo[4.1.0]heptan-2-yl]amino}oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3,5,6-tetrahydroxyhexanal

C25H43NO20 (677.2378318000001)


   

[18,21-bis(acetyloxy)-19,24,25-trihydroxy-3,13,14,25-tetramethyl-6,15,22-trioxo-2,5,16-trioxa-11-azapentacyclo[15.7.1.0¹,²⁰.0³,²³.0⁷,¹²]pentacosa-7,9,11-trien-20-yl]methyl acetate

[18,21-bis(acetyloxy)-19,24,25-trihydroxy-3,13,14,25-tetramethyl-6,15,22-trioxo-2,5,16-trioxa-11-azapentacyclo[15.7.1.0¹,²⁰.0³,²³.0⁷,¹²]pentacosa-7,9,11-trien-20-yl]methyl acetate

C32H39NO15 (677.2319584)


   

8-benzyl-10,17,24-trihydroxy-15,26-dimethyl-22-(sec-butyl)-27-oxa-13,20-dithia-6,9,16,23,28,29,30-heptaazapentacyclo[23.2.1.1¹¹,¹⁴.1¹⁸,²¹.0²,⁶]triaconta-1(28),9,11,14(30),16,18,21(29),23-octaen-7-one

8-benzyl-10,17,24-trihydroxy-15,26-dimethyl-22-(sec-butyl)-27-oxa-13,20-dithia-6,9,16,23,28,29,30-heptaazapentacyclo[23.2.1.1¹¹,¹⁴.1¹⁸,²¹.0²,⁶]triaconta-1(28),9,11,14(30),16,18,21(29),23-octaen-7-one

C33H39N7O5S2 (677.2453964)


   

(1s,2r,5s,6s,8r,9s,10r,12s,15r,16s,25r,27s,28r)-21-bromo-15,16,33,33-tetramethyl-24-methylidene-10-(prop-1-en-2-yl)-7,11,32-trioxa-18-azadecacyclo[25.4.2.0²,¹⁶.0⁵,¹⁵.0⁶,⁸.0⁶,¹².0¹⁷,³¹.0¹⁹,³⁰.0²²,²⁹.0²⁵,²⁸]tritriaconta-17(31),19,21,29-tetraene-5,9,28-triol

(1s,2r,5s,6s,8r,9s,10r,12s,15r,16s,25r,27s,28r)-21-bromo-15,16,33,33-tetramethyl-24-methylidene-10-(prop-1-en-2-yl)-7,11,32-trioxa-18-azadecacyclo[25.4.2.0²,¹⁶.0⁵,¹⁵.0⁶,⁸.0⁶,¹².0¹⁷,³¹.0¹⁹,³⁰.0²²,²⁹.0²⁵,²⁸]tritriaconta-17(31),19,21,29-tetraene-5,9,28-triol

C37H44BrNO6 (677.2351824)


   

(1s,2s,3r,4s,5r,6r)-5-{[(2s,3s,4s,5r,6r)-6-{[(2r,3s,4r,5r,6r)-4,5-dihydroxy-2-(hydroxymethyl)-6-{[(2r,3s,4r,5r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxan-3-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]amino}-1-(hydroxymethyl)-7-oxabicyclo[4.1.0]heptane-2,3,4-triol

(1s,2s,3r,4s,5r,6r)-5-{[(2s,3s,4s,5r,6r)-6-{[(2r,3s,4r,5r,6r)-4,5-dihydroxy-2-(hydroxymethyl)-6-{[(2r,3s,4r,5r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}oxan-3-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]amino}-1-(hydroxymethyl)-7-oxabicyclo[4.1.0]heptane-2,3,4-triol

C25H43NO20 (677.2378318000001)